TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharmbiotech Oy
Closing information (x1000 EUR)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover | 2,000 | 47 | 0 |
Financial expenses | 15 | 0 | |
Earnings before taxes | 564 | 188 | -5 |
Total assets | 761 | 2,609 | 2,413 |
Current assets | 368 | 393 | 1,993 |
Current liabilities | 2 | 2,026 | 2,004 |
Equity capital | 8 | 17 | 9 |
- share capital | 3 | 3 | 3 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency | 1.1% | 0.7% | 0.4% |
Turnover per employee | |||
Profit as a percentage of turnover | 28.2% | 400% | |
Return on assets (ROA) | 7.8% | -0.2% | |
Current ratio | 18400% | 19.4% | 99.5% |
Return on equity (ROE) | 7050.0% | 1105.9% | -55.6% |
Change turnover | 1,953 | 47 | |
Change turnover % | 4155% | ||
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.